Jeffrey Allen at [NYU Langone Medical Center]

Jeffrey C. Allen, MD

  • Specialties: Pediatric Oncology, Pediatric Neurology, Neurology
  • Language: English
  • Phone: 212-263-9907

About Me

As a pediatric neurologist and a neuro-oncologist at NYU Langone, I aim to improve the care of children and young adults who have primary central nervous system tumors, peripheral nerve tumors, and neurofibromatosis types 1 and 2—genetic conditions that can result in noncancerous tumors.

Through clinical and translational research tools and methods, I aim to better understand the natural history of central nervous system tumors with the intention of refining treatment to make it safer and more effective.

In 2008, I helped organize the team of physicians at NYU Langone that established the first Comprehensive Neurofibromatosis Center. We currently offer care and clinical trials for children and adults with neurofibromatosis types 1 and 2 and schwannomatosis.

In 2011, I was the principal investigator for a successful application to become a member of the Neurofibromatosis Clinical Trials Consortium, which is funded by the United States Department of Defense and includes 12 institutions within the United States. This affiliation gives our patients with neurofibromatosis access to advanced and innovative clinical trials.

Conditions and Treatments

brain tumor, spinal cord tumor, neurofibromatosis, peripheral nervous system neoplasms


  • Otto and Marguerite Manley and Making Headway Foundation Professor of Pediatric Neuro-Oncology, Department of Pediatrics
  • Professor, Department of Neurology
Board Certifications
  • American Board of Psychiatry & Neurology - w/Spec Qual"s In Child Neurolo, 1977
Education and Training
  • Residency, Montreal Children's Hospital, Pediatrics, 1976
  • MD from Harvard Medical School, 1969

Locations and Appointments

65 Insurance Plans Accepted
  • Aetna HMO
  • Aetna Indemnity
  • Aetna Medicare
  • Aetna POS
  • Aetna PPO/EPO
  • Affinity
  • Affinity Exchange- Essential
  • Cigna EPO/POS
  • Cigna PPO
  • ElderPlan
  • Empire Blue Cross Blue Shield EPO
  • Empire Blue Cross Blue Shield HMO
  • Empire Blue Cross Blue Shield Indemnity
  • Empire Blue Cross Blue Shield MediBlue
  • Empire Blue Cross Blue Shield POS
  • Empire Blue Cross Blue Shield PPO
  • Empire Blue Cross Blue Shield Pathways, Enhanced
  • Fidelis Child Health
  • Fidelis Exchange
  • Fidelis Family Health
  • Fidelis Medicaid
  • Fidelis Medicare
  • HIP Access I
  • HIP Access II
  • HIP Child Health
  • HIP Family Health
  • HIP Medicaid
  • HIP Medicare
  • HealthPlus Child Health (Amerigroup)
  • HealthPlus Family Health (Amerigroup)
  • HealthPlus Medicaid (Amerigroup)
  • HealthRepublic
  • HealthSmart (WTC)
  • Humana Medicare
  • Local 1199 PPO
  • MagnaCare PPO
  • Medicare
  • MetroPlus Child Health
  • MetroPlus Exchange Plans
  • MetroPlus Family Health
  • MetroPlus Medicaid
  • MetroPlus Medicare
  • MultiPlan/PHCS PPO
  • NY Medicaid
  • NYS Empire Plan
  • Oscar
  • Oxford Exchange
  • Oxford Freedom
  • Oxford Liberty
  • Oxford Medicare
  • UPN Elite
  • United Exchange- Compass
  • UnitedHealthcare Community & State Plan
  • UnitedHealthcare EPO
  • UnitedHealthcare HMO
  • UnitedHealthcare Medicare
  • UnitedHealthcare POS
  • UnitedHealthcare PPO
  • UnitedHealthcare Top Tier
  • Village Caremax
  • Visiting Nurse Service (VNS) Medicare
*Insurance listed above may not be accepted at all office locations. Please confirm prior to each visit. The information presented here may not be complete or may have been changed.
Stephen D. Hassenfeld Childrens Center for Cancer & Blood Disorders

160 East 32nd Street, 3rd Floor
New York, NY 10016


Phone: 212-263-9907

NYU Pediatric Oncology Associates

317 East 34th Street
New York, NY 10016


Phone: 212-263-8400

Welcome back!

As a returning patient for this doctor, please schedule an appointment using your MyChart at NYU Langone account.

Learn more about MyChart at NYU Langone.

My Research

A Brain Tumor Research Center at NYU School of Medicine was established in 1992 with an award from the National Institute of Neurological Disorders and Stroke to support a tumor bank, a patient database, and five research projects concentrating on: 1) tumor suppressor genes in genetically high risk pediatric brain tumor populations, 2) interaction of recessive and dominant oncogenes, 3) growth factors, 4) cell adhesion molecules, and 5) cellular immunology. The tumor bank has accrued over 3000 frozen/formalin fixed human brain, spinal and peripheral nerve tumor specimens and the patient and neurofibromatosis database tracks over patients. This unique resource facilitates many institutional and collaborative research projects and is funded by grants from the Making Headway Foundation. The Brain Tumor Research Center also facilitates clinical research neuro-oncology protocols, both institutional and cooperative group trials, and actively engages in pharmaceutical collaborations. The NYU Comprehensive Neurofibromatosis Center was initiated in 2008 and is rapidly evolving with acquisition of new staff members. We received a coveted award to become a member of the NF Clinical Trials Consortium in 2011 which offers our patients with NF1 and NF2 access to advanced clinical trials.



  • Ovarian function in survivors of childhood medulloblastoma: Impact of reduced dose craniospinal irradiation and high-dose chemotherapy with autologous stem cell rescue

    Balachandar, S; Dunkel, IJ; Khakoo, Y; Wolden, S; Allen, J; Sklar, CA
    Pediatric blood & cancer. 2015. 62 (2): 317-321

  • Phase II Trial Assessing the Ability of Neoadjuvant Chemotherapy With or Without Second-Look Surgery to Eliminate Measurable Disease for Nongerminomatous Germ Cell Tumors: A Children's Oncology Group Study

    Goldman, Stewart; Bouffet, Eric; Fisher, Paul G; Allen, Jeffrey C; Robertson, Patricia L; Chuba, Paul J; Donahue, Bernadine; Kretschmar, Cynthia S; Zhou, Tianni; Buxton, Allen B; Pollack, Ian F
    Journal of clinical oncology. 2015 Jun. ?-? e0130027

  • Management of CNS germinoma

    Osorio, Diana S; Allen, Jeffrey C
    CNS oncology. 2015 Jun. 4 (4): 273-279

Read All Publications (323)